Polymers in Drug Delivery: Shaping the Future of Advanced Therapeutics

by Curapath

Polymers are emerging as powerful alternatives to viral vectors for DNA delivery, enabling safer and more flexible approaches for DNA vaccines and in vivo CAR-T therapies.

Read more

Josep Samitier – Nanobioengineering group leader at IBEC and former director of IBEC

by GENESIS Biomed

Josep Samitier: “It’s key to strengthen public-private collaboration and attract venture capital to promote emerging projects that will allow us to consolidate technological and productive capacit...

Read more

La FDA aprueba en Estados Unidos el primer medicamento de terapia génica desarrollado a partir de una investigación española

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

La Agencia Estadounidense de Alimentos y Medicamentosha aprobado el medicamento de terapia génica denominado KRESLADI™ (marnetegragene autotemcel) de la empresa Rocket Pharma para el tratamiento de...

Read more

Curapath and Nacalai Tesque Partner to Expand Access to next generation Polymers and PEG-Free Shielding Lipids in Japan

by Curapath

​Curapath has partnered with ​Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan.

Read more

VIVEbiotech and Zelluna Partnership to Advance Off-the-Shelf TCR-NK Cell Therapy with GMP Lentiviral Vectors

by VIVEbiotech

Partnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP ex- and in- vivo lentiviral vectors for the advanced therapies sector

Read more

VIVEbiotech Expands Lentiviral Vector Manufacturing Capabilities with EvoLVcell

by VIVEbiotech

Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability.

Read more

Autorización de uso frente a autorización de medicamento en Terapias Avanzadas: diferencias clave desde la investigación clínica

by Sermes CRO

El escenario regulatorio de las Terapias Avanzadas es complejo. En él conviven autorizaciones de uso hospitalario con medicamentos plenamente aprobados por la EMA. Entender esta dualidad permite anti...

Read more

La terapia génica afronta nuevos desafíos en el tratamiento de las enfermedades neurológicas

by Cima Universidad de Navarra

Científicos, empresas de biotecnología y farmacéuticas, fondos de inversión y asociaciones de pacientes se han reunido en Pamplona para debatir los nuevos desafíos en el tratamiento de enfermedad...

Read more

VIVEbiotech adds newest in vivo lentiviral vector-based therapeutic programs

by VIVEbiotech

Now advancing 15 next-generation in vivo therapies through high-performance, scalable lentiviral vector manufacturing capabilities

Read more

A gene therapy prolongs health span and preserves the function of organs in mice during aging

by Universitat Autònoma de Barcelona (UAB)

A research team from the Universitat Autònoma de Barcelona (UAB) has shown that a one-time administration of a gene therapy expressing the metabolic factor FGF21 can prolong health span in old mice....

Read more

Vall d’Hebron participates in a natural history study of CTNNB1 syndrome

by Vall d’Hebron

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

Read more

SJD Barcelona has been awarded European MIA accreditation to produce advanced therapies for other centres

by Hospital Sant Joan de Déu

It is the first centre in Spain to achieve this accreditation, which places its operations on a par with those of a pharmaceutical laboratory and consolidates the leadership of the Advanced Therapies ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream